Max Harms investigates Nectome's brain preservation startup, which offers advanced cryonics procedures at $20k until end of April—a potential 92% discount despite significant business uncertainties.

Max Harms, an AI alignment researcher at MIRI, visited Oregon to evaluate Nectome's entire team and operations

Nectome's brain preservation procedure is reportedly significantly more effective at preserving people than competing cryonics organizations

Early-bird pricing of $20k (down from theoretical $250k) is available only until end of April due to business uncertainties

Harms purchased two procedures himself, while acknowledging his long-standing cryonics enthusiasm may bias his perspective

The company aims for ambitious growth unlike any previous cryonics organization, though faces challenges in both the broader market and operational execution